Premier Path Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Premier Path Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.98M	Sell	3,945 -437	-10%	-$210K	0.23%	99
2026 Q1	$2.15M	Buy	4,382 +73	+2%	+$39.6K	0.28%	82
2025 Q4	$2.5M	Sell	4,309 -245	-5%	-$139K	0.32%	71
2025 Q3	$2.21M	Buy	4,554 +2,908	+177%	+$1.35M	0.28%	78
2025 Q2	$667K	Sell	1,646 -247	-13%	-$103K	0.09%	218
2025 Q1	$942K	Buy	1,893 +104	+6%	+$56.3K	0.15%	168
2024 Q4	$931K	Sell	1,789 -84	-4%	-$46.2K	0.14%	164
2024 Q3	$1.16M	Sell	1,873 -13	-0.7%	-$7.7K	0.18%	143
2024 Q2	$1.04M	Buy	1,886 +13	+0.7%	+$7.45K	0.18%	142
2024 Q1	$1.09M	Sell	1,873 -56	-3%	-$31.4K	0.2%	129
2023 Q4	$1.02M	Buy	+1,929	New	+$934K	0.23%	115

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Premier Path Wealth Partners's TMO Position: Q2 2026 in Review

Premier Path Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 10% in Q2 2026, selling an estimated $210K and leaving 3,945 shares worth $1.98M. The position accounts for 0.23% of the portfolio, ranked #99.

Premier Path Wealth Partners first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.5M in Q4 2025. 982 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Premier Path Wealth Partners held 3,945 shares of Thermo Fisher Scientific worth $1.98M as of Q2 2026.
Premier Path Wealth Partners sold 437 Thermo Fisher Scientific shares in Q2 2026, an estimated $210K.
Thermo Fisher Scientific made up 0.23% of Premier Path Wealth Partners's portfolio in Q2 2026, its #99 holding.
Premier Path Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
Premier Path Wealth Partners's Thermo Fisher Scientific position peaked at $2.5M in Q4 2025.
982 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Premier Path Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.